tm
Seeing Is Believing
tm
Seeing Is Believing
CGTX is currently covered by 2 analysts with an average price target of $4.67. This is a potential upside of $3.58 (328.44%) from yesterday's end of day stock price of $1.09.
Cognition Therapeutics's activity chart (see below) currently has 11 price targets and 24 ratings on display. The stock rating distribution of CGTX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 12% with an average time for these price targets to be met of 53.6 days.
Highest price target for CGTX is $4, Lowest price target is $2, average price target is $3.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 04-Dec-2025. First documented stock forecast 03-Nov-2021.
Currently out of the existing stock ratings of CGTX, 6 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-May-2024
$3
$1.91 (175.23%)
$3
1 months 28 days ago
(04-Dec-2025)
0/3 (0%)
$1.24 (70.45%)
Buy
$4
$2.67 (200.75%)
$8
8 months 24 days ago
(08-May-2025)
0/2 (0%)
$3.67 (1112.12%)
Buy Since 19-Dec-2024
$2
$0.91 (83.49%)
$1.5
11 months 26 days ago
(06-Feb-2025)
3/5 (60%)
$1.36 (212.50%)
268
Buy Since 03-Nov-2021
$9
$7.91 (725.69%)
$9
1 years 10 months 5 days ago
(27-Mar-2024)
0/3 (0%)
$7.18 (394.51%)
Buy Since 22-Apr-2022
$6
$4.91 (450.46%)
$10
2 years 5 months 18 days ago
(14-Aug-2023)
0/2 (0%)
$4.47 (292.16%)
What is CGTX (Cognition Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CGTX (Cognition Therapeutics) with a proven track record?
Which analyst has the current lower performing score on CGTX (Cognition Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CGTX (Cognition Therapeutics)?
Which analyst is the currently most bullish on CGTX (Cognition Therapeutics)?
Which analyst is the currently most reserved on CGTX (Cognition Therapeutics)?
